We are live on ! Find out more
ProShare Advisors

ProShare Advisors Portfolio holdings

AUM $67.5B
1-Year Est. Return 28.09%
This Fund
S&P 500
This Quarter Est. Return
+9.54%
1 Year Est. Return
+28.09%
3 Year Est. Return
+88.43%
5 Year Est. Return
+118.21%
10 Year Est. Return
+464.8%
AUM
$21.6B
AUM Growth
+$3.73B
Cap. Flow
+$2.14B
Cap. Flow %
9.89%
Top 10 Hldgs %
20.71%
Holding
1,837
New
181
Increased
1,318
Reduced
286
Closed
50

Top Buys

Rank Stock Value
1
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$34M
2
XOM icon
ExxonMobil
XOM
+$33.1M
3
JNJ icon
Johnson & Johnson
JNJ
+$32.7M
4
MMM icon
3M
MMM
+$32.4M
5
MCD icon
McDonald's
MCD
+$32.3M

Sector Composition

Rank Sector Weight
1 Technology 20.41%
2 Financials 12.4%
3 Industrials 11.69%
4 Healthcare 11.57%
5 Consumer Staples 11.08%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SYRE icon
1801
Spyre Therapeutics
SYRE
$8.64B
-432
Closed -$83K
TNK icon
1802
Teekay Tankers
TNK
$2.51B
-2,712
Closed -$28K
VSTM icon
1803
Verastem
VSTM
$512M
-1,673
Closed -$24K
XERS icon
1804
Xeris Biopharma Holdings
XERS
$1.5B
-10,344
Closed -$102K
TECX
1805
Tectonic Therapeutic
TECX
$609M
-910
Closed -$154K
PETQ
1806
DELISTED
PetIQ, Inc. Class A Common Stock
PETQ
-8,431
Closed -$230K
KA
1807
DELISTED
Kineta, Inc. Common Stock
KA
-99
Closed -$12K
ASXC
1808
DELISTED
Asensus Surgical, Inc.
ASXC
-1,613
Closed -$13K
PRTK
1809
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
-12,454
Closed -$54K
KDNY
1810
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
-5,831
Closed -$31K
ACOR
1811
DELISTED
Acorda Therapeutics
ACOR
-161
Closed -$56K
CLVS
1812
DELISTED
Clovis Oncology, Inc.
CLVS
-20,532
Closed -$81K
ELOX
1813
DELISTED
Eloxx Pharmaceuticals, Inc. Common Stock
ELOX
-342
Closed -$62K
POLY
1814
DELISTED
Plantronics, Inc.
POLY
-6,333
Closed -$236K
ADMS
1815
DELISTED
Adamas Pharmaceuticals
ADMS
-10,090
Closed -$52K
SBBP
1816
DELISTED
Strongbridge Biopharma plc.
SBBP
-18,794
Closed -$45K
FPRX
1817
DELISTED
Five Prime Therapeutics, Inc.
FPRX
-13,884
Closed -$54K
GWR
1818
DELISTED
Genesee & Wyoming Inc.
GWR
-4,516
Closed -$499K
CRZO
1819
DELISTED
Carrizo Oil & Gas Inc
CRZO
-12,468
Closed -$107K
ASNA
1820
DELISTED
Ascena Retail Group, Inc.
ASNA
-914
Closed -$5K
ONCE
1821
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
-14,334
Closed -$1.39M
STI
1822
DELISTED
SunTrust Banks, Inc.
STI
-142,382
Closed -$9.8M
CBM
1823
DELISTED
Cambrex Corporation
CBM
-4,690
Closed -$279K
VIAB
1824
DELISTED
Viacom Inc. Class B
VIAB
-137,629
Closed -$3.31M
DOVA
1825
DELISTED
Dova Pharmaceuticals, Inc. Common Stock
DOVA
-8,744
Closed -$244K

Similar funds

ProShare Advisors's Q4 2019 Portfolio in Review

As of Q4 2019, ProShare Advisors held 1,837 positions worth $21.6B, up 21% from $17.9B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

ProShare Advisors deployed $2.14B of net new capital in Q4 2019, opening 181 new positions and adding to 1,318 existing holdings. Its largest new stake was Pennant Group: 484,308 shares worth $16M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Financials and Industrials.

On the sell side, the largest reduction was W.R. Berkley, an estimated $12.8M trimmed.

  • ProShare Advisors's largest Q4 2019 buy was Pennant Group: 484,308 shares worth $16M.
  • ProShare Advisors added most to Alphabet (Google) Class A in Q4 2019, an estimated $34M increase.
  • ProShare Advisors's biggest Q4 2019 reduction was W.R. Berkley, cutting an estimated $12.8M.
  • ProShare Advisors fully exited Celgene Corp in Q4 2019, selling an estimated $70M.
  • ProShare Advisors's ten largest holdings make up 21% of its $21.6B portfolio in Q4 2019.
  • ProShare Advisors opened 181 new positions and closed 50 in Q4 2019.
  • ProShare Advisors's portfolio value rose 21% quarter-over-quarter to $21.6B.

Based on ProShare Advisors's 13F filing for Q4 2019, filed 12 Feb 2020.